Go to deals
Opieka zdrowotna

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Shield is a de-risked, specialty pharmaceutical company focused on commercializing its lead product, Feraccru®/Accrufer®, a novel, non-salt-based oral therapy for adults with iron deficiency with or without anemia.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as the joint broker on this transaction.

Usługi
Funding, debt advisory & ECM
Strony

Porozmawiaj z zespołem obsługi transakcji

 Geoff  Nash

Geoff Nash

Partner

Londyn, Wielka Brytania
Oaklins Cavendish

Powiązane transakcje

Groupe Nature acquires Winco
Dobra konsumpcyjne i handel detaliczny | Opieka zdrowotna

Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Więcej informacji
Camelia pharmacy chain has been acquired by Medigate Management UAB
Dobra konsumpcyjne i handel detaliczny | Opieka zdrowotna

Camelia pharmacy chain has been acquired by Medigate Management UAB

CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.

Więcej informacji
Jersey Oil & Gas has completed a private placement of new shares
Energetyka

Jersey Oil & Gas has completed a private placement of new shares

Jersey Oil & Gas Plc has raised funds to support a new development project.

Więcej informacji